The European Medicines Verification System (EMVS) has passed another significant milestone in its development process by successfully implementing its first Hub connection with a Member State. This achievement is a major step along the road to securing the legitimate pharmaceutical supply chain against the risk of falsified medicines.

On July 1, the link was established between the European hub and the German repository system, managed by the German stakeholder organisation securPharm. Pharmaceutical manufacturers will now be able to upload their serialised data onto the system. At this stage 16 companies have committed to take part in the rollout of the system and to establish a connection with the Hub.

The cooperation between the European Medicines Verification Organisation (EMVO) and securPharm marks the start of the European Medicines Verification System. The essential link forms the Hub, which will ensure the pan-European interoperability of the EMVS and serve as a central entry point for companies to upload data.

It also means that the EMVO/Hub is now able to fulfil its four-pillared mission to safeguard the European supply chain against of the risk of falsified medicines. Andreas Walter, EMVO Director General ad-interim quotes: “It is now capable of comprehensibly: securing cross-border trade; ensuring interoperability between national systems; supporting the establishment of standard interfaces and providing cost savings for connecting manufacturers at a single entry point”.

Media Contacts

Andreas M. WALTER
Director General a.i.
EMVO
c/o EFPIA Communications
Phone: +32 2 626 25 55
Email: communications@efpia.eu

About EMVO

The European Medicines Verification Organisation (EMVO) is a Luxembourgish non-profit organisation representing stakeholders united in securing the legal supply chain from falsified medicines. Its founding members are EFPIA, the European Federation of Pharmaceutical Industries and Associations, the EGA, the European Generic and Biosimilar medicines Association, PGEU, the Pharmaceutical Group of the European Union, GIRP, the European Association of Pharmaceutical Full-line Wholesalers and EAEPC, the European Association of Euro-Pharmaceutical Companies.